Partnership aims for CAP/CLIA certification of organoid-based assay to guide patient-specific treatment decisions; $10 million investment to fuel clinical validation across multiple cancer types ...
By aligning regulatory rigour with technological complexity, the FDA safeguards public health while accelerating access to life-changing medical innovations through adaptive pathways and total lifecycle vigilance...
First camera-agnostic motion tracking solution for laparoscopic surgery delivers real-time insight into surgical technique and proficiency across all devices and operating rooms ...
First and only purpose-built solution delivering rapid and complete luminal clot removal in small vessel and arteriovenous access cases...
First in the industry to achieve dual certification for both reagents and analysers within its Atellica portfolio...
Developed with PacBio's PureTarget technology, the new test enhances identification of complex DNA repeat expansions to support accurate diagnosis and care for patients with neurological disorders ...
New Metrix Filovirus Panel to deliver 30-minute, lab-quality results from blood samples in remote and point-of-care settings—marking a pivotal step in global outbreak preparedness. ...
Breakthrough findings for QyScore® and QyPredict® highlight enhanced accuracy in brain segmentation and early identification of cognitive decline, paving the way for improved clinical trials and patient outcomes in Alzheimer’s disease. ...
New magnetic ablation catheter designed to enhance precision and reach in robotic electrophysiology procedures across the U.S....
Launched at AAIC 2025, the ultra-sensitive assays aim to improve early detection, disease monitoring, and biomarker discovery in neurodegenerative research....
